| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 8,410 | 9,050 | 20:10 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.11. | Nexstim Oyj: Nexstim Plc appoints Ville Saarainen as new CTO | 310 | GlobeNewswire (Europe) | Press release, Helsinki, 4 November 2026 at 3 PM (EET)
Nexstim Plc appoints Ville Saarainen as new CTO
Nexstim Plc ("Nexstim" or "Company") announces that Gustaf Järnefelt has decided to retire and... ► Artikel lesen | |
| 02.11. | Nexstim Plc: Shares Subscribed With Option Rights | 219 | GlobeNewswire | NOTICE, NOVEMBER 02, 2026 SHARES (Record Id 369801)
A total of 47,025 shares will be traded as old shares as of November 03, 2026... ► Artikel lesen | |
| 29.10. | Nexstim Oyj: Nexstim Receives Order for NBS 6 System from Finnish Hospital | 164 | GlobeNewswire (Europe) | Press Release, Helsinki, 29 October 2026 at 9 AM (EEST)
Nexstim Receives Order for NBS 6 System from Finnish Hospital
Nexstim Plc ("Nexstim" or "Company") has received an order for one NBS 6 System.
The... ► Artikel lesen | |
| 23.10. | Nexstim Oyj: Nexstim Plc Business Update Q3 2026 | 278 | GlobeNewswire (Europe) | Press release, Helsinki, 23 October 2026 at 9 AM (EEST)
Nexstim Plc Business Update Q3 2026
Nexstim Plc ("Nexstim" or "Company") announces the key highlights of the Company's business operations during... ► Artikel lesen | |
| 14.10. | Nexstim Oyj: Nexstim and Brainlab Advance Neuroscience Capabilities in Portugal with Installation at Hospital da Luz Lisboa | 295 | GlobeNewswire (Europe) | Press Release, Helsinki, 14 October 2026 at 9 AM (EEST)
Nexstim and Brainlab Advance Neuroscience Capabilities in Portugal with Installation at Hospital da Luz Lisboa
Nexstim Plc (NXTMH:HEX) ("Nexstim"... ► Artikel lesen | |
| 09.10. | Original-Research: Nexstim Oyj (von NuWays AG): BUY | 506 | EQS Group (EN) | Original-Research: Nexstim Oyj - from NuWays AG
09.10.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the... ► Artikel lesen | |
| NEXSTIM Aktie jetzt für 0€ handeln | |||||
| 02.09. | Original-Research: Nexstim (von NuWays AG): BUY | 567 | EQS Group (EN) | Original-Research: Nexstim - from NuWays AG
02.09.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content... ► Artikel lesen | |
| 02.09. | Stimulating growth with surgical accuracy; INITIATE with BUY: We initate Nexstim coverage with a BUY ... | 600 | NuWays | Nexstim is a Finnish MedTech company and a global leader in navigated transcranial magnetic stimulation (nTMS) technology. With nTMS, Nexstim helps (i) surgeons preserve patients' motor and speech cortices... ► Artikel lesen | |
| 21.08. | Nexstim Oyj: Nexstim Receives NBS 6 System Order for a European hospital and existing Nexstim customer | 304 | GlobeNewswire (Europe) | Press release, Helsinki, 21 August 2026 at 9 AM (EEST)
Nexstim Receives NBS 6 System Order for a European hospital and existing Nexstim customer
Nexstim Plc ("Nexstim" or "Company") has received an... ► Artikel lesen | |
| 14.08. | Nexstim meldet Umsatzwachstum für H1 2026 und Rekord-Auftragsbestand | 2 | Investing.com Deutsch | ||
| 14.08. | Nexstim Oyj: Nexstim Plc Half-year Report January 1 - June 30, 2026 (unaudited) | 271 | GlobeNewswire (Europe) | Company announcement, Helsinki, August 14, 2026 at 9 am (EEST)
NEXSTIM PLC HALF-YEAR REPORT JANUARY 1 - JUNE 30, 2026 (UNAUDITED)
NEXSTIM CONTINUED ITS GROWTH AND STRENGHTENED ITS FINANCIAL POSITION
The... ► Artikel lesen | |
| 14.07. | Nexstim Oyj: Nexstim Receives a New Order for Ten NBS 6 Systems from Distributor | 367 | GlobeNewswire (Europe) | Press Release, Helsinki, 14 July 2026 at 9 AM (EEST)
Nexstim Receives a New Order for Ten NBS 6 Systems from Distributor
Nexstim Plc ("Nexstim" or "Company") has received a new order for ten NBS 6 systems... ► Artikel lesen | |
| 13.05. | Nexstim Oyj: Inside Information: Nexstim Plc Announces EUR 5 Million Investment from Eiffel and from Brainlab and Conversion of Options by Certain Option Holders | 563 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 13 May 2026 at 09:05 AM (EEST)
Inside Information: Nexstim Plc Announces EUR 5 Million Investment from Eiffel and from Brainlab and Conversion of Options by Certain... ► Artikel lesen | |
| 28.04. | Nexstim Oyj: Nexstim Plc Business Update Q1 2026 | 535 | GlobeNewswire (Europe) | Press release, Helsinki, 28 April 2026 at 9 AM (EEST)
Nexstim Plc Business Update Q1 2026
Nexstim Plc ("Nexstim" or "Company") announces the key highlights of the Company's business operations during... ► Artikel lesen | |
| 17.04. | Nexstim Oyj: Nexstim Plc establishes Restricted Share Unit plan for extended management team for earning periods 2026-2029 | 257 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 17 April 2026 at 9 AM (EEST)
Nexstim Plc establishes Restricted Share Unit plan for extended management team for earning periods 2026-2029
The Board of Directors of Nexstim... ► Artikel lesen | |
| 30.03. | Nexstim Oyj: Nexstim Plc: Resolutions of the Annual General Meeting | 260 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 30 March 2026 at 1:30 PM (EEST)
Nexstim Plc: Resolutions of the Annual General Meeting
Nexstim Plc ("Nexstim" or "Company") announces the following resolutions of the... ► Artikel lesen | |
| 23.03. | Nexstim Oyj: Nexstim's NBS System 6 gains FDA clearance for treatment of Obsessive Compulsive Disorder (OCD) | 469 | GlobeNewswire (Europe) | Press release, Helsinki, 23 March 2026 at 10:30 AM (EET)
Nexstim's NBS System 6 gains FDA clearance for treatment of Obsessive Compulsive Disorder (OCD)
Nexstim Plc ("Nexstim" or "Company") announces... ► Artikel lesen | |
| 26.02. | Nexstim Oyj: Nexstim Plc's Financial Statements Bulletin 2025 | 694 | GlobeNewswire (Europe) | Company announcement, Helsinki 26 February 2026 at 9 am (EET)
NEXSTIM PLC'S FINANCIAL STATEMENTS BULLETIN 2025
NEXSTIM ACCELERATED GROWTH AND ACHIEVED A PROFITABLE RESULT
January-December 2025
The... ► Artikel lesen | |
| 19.02. | Nexstim Oyj: Nexstim's NBS 6 system receives MDR certification in the EU for use in Post-Operative Rehabilitation | 326 | GlobeNewswire (Europe) | Press release, Helsinki, 19 February 2026 at 9 AM (EET)
Nexstim's NBS 6 system receives MDR certification in the EU for use in Post-Operative Rehabilitation
Nexstim Plc ("Nexstim" or "Company") has... ► Artikel lesen | |
| 16.02. | Nexstim Oyj: Nexstim Receives Clearance for its NBS 6 Diagnostics System in UAE | 690 | GlobeNewswire (Europe) | Press release, Helsinki, 16 February 2026 at 11:30 AM (EET)
Nexstim Receives Clearance for its NBS 6 Diagnostics System in UAE
Nexstim Plc ("Nexstim" or "Company") has received import clearance for... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences GAAP EPS of $0.00, revenue of $4.63M | ||
| VERU | 2,330 | +9,39 % | Veru presents data on enobosarm for obesity treatment | ||
| NYXOAH | 0,760 | -2,06 % | Nyxoah obtains default judgment in patent infringement case against Inspire Medical Systems | ||
| OPTOMED | 1,874 | 0,00 % | Optomed Oyj: Interim report January - September 2026 | Optomed Plc Stock Exchange Release 6 November 2026 at 9.00, Helsinki Optomed Plc: Interim report January - September 2026
July - September 2026
Revenue increased by 17.5 percent to EUR 5.2 (4.4)... ► Artikel lesen | |
| MODULIGHT | 1,040 | -3,70 % | Modulight Oyj: Inside Information: Modulight receives USD 1.1 million order from new quantum computing customer | Modulight Corporation | Inside Information | November 04, 2026 at 18:39:00 EET
Modulight Corporation has received an order worth USD 1.1 million from a US quantum computing company that is a new customer... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,560 | -2,90 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius kündigt Verkauf von rund 13,4 Millionen Aktien der Fresenius Medical Care AG an - Finanzbeteiligung soll auf rund 20 Prozent sinken | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Sonstiges
Fresenius kündigt Verkauf von rund 13,4 Millionen Aktien der Fresenius Medical Care AG an - Finanzbeteiligung soll... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,840 | +1,25 % | Aktie zieht an!: Siemens liefert und legt nach, die Strategie überzeugt wirft Fragen auf | © Foto: Joko - JokoSiemens meldet Rekordzahlen und hebt die Mittelfristziele an. Anleger bleiben trotzdem skeptisch, denn die neue Konzernstrategie gilt vielen noch als zu unscharf Enthaltene Werte:... ► Artikel lesen | |
| FRESENIUS | 53,43 | -0,60 % | mAbxience and OncoPrecision Announce Manufacturing and Investment Agreement for OncoPrecision's ADC Candidate ONC001 | mAbxience and OncoPrecision Announce Manufacturing and Investment Agreement for OncoPrecision's ADC Candidate ONC001
MADRID, Nov. 18, 2026 /PRNewswire/ -- mAbxience, a wholly owned company of Fresenius... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 25,270 | +1,08 % | Privia Health Group, Inc.: Privia Health Reports Strong Results in the 2025 Performance Year of the Medicare Shared Savings Program | ||
| BILLIONTOONE | 91,72 | -5,99 % | BillionToOne falls after Fuzzy Panda Research short report | ||
| CARL ZEISS MEDITEC | 32,260 | -6,22 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Underweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 27 auf 26 Euro gekappt und die Aktien von "Equal Weight" auf "Underweight" abgestuft. Dem... ► Artikel lesen | |
| GERRESHEIMER | 33,200 | +3,81 % | Gerresheimer: Jetzt muss das Schlussquartal liefern | ||
| BRIGHTSPRING HEALTH SERVICES | 69,35 | -0,69 % | BMO raises BrightSpring Health stock price target on LDD momentum | ||
| LIFESTANCE HEALTH GROUP | 13,795 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| OTTOBOCK | 37,750 | -1,56 % | JEFFERIES stuft Ottobock auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Ottobock nach Zahlen mit einem Kursziel von 83 Euro auf "Buy" belassen. Henrik Paganetty attestierte dem Prothesenhersteller... ► Artikel lesen |